Table 4.
Haemostatic treatments.
Treatment | n (%) | Doses (U) | ||
---|---|---|---|---|
Range | Median | IQR | ||
Recombinant FVIIa | 15 (57.70) | 5–670 | 70.00 | 27–151 |
aPCC | 3 (11.50) | 42,000–150,000 | 124,000 | * |
Human FVIII | 25 (96.10) | 5000–722,000 | 111,000 | 63,000–205,000 |
IQR, interquartile range. * Not calculated for the number of events. FVIIa, activated recombinant Factor VII; aPCC, activated prothrombin complex concentrate; FVIII: Factor VIII.